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The participation of C-reactive protein (CRP) in host defense against microorganisms has been well described. 
More controversial has been its role in chronic conditions such as cardiovascular disease. Our recent 
publications explain the reasons for some of the confusion concerning CRP as a risk factor for disease and 
whether it is pro-inflammatory or anti-inflammatory. We found that two isoforms of CRP, pentameric (pCRP) 
and monomeric (mCRP), on microparticles (MPs), were not measureable by standard clinical assays. When we 
investigated MPs by imaging cytometry in plasma from controls versus patients with peripheral artery disease, 
we found that MPs from endothelial cells bearing mCRP were elevated. This elevation did not correlate with the 
soluble pCRP measured by high-sensitivity CRP assays. The data suggest that detection of mCRP on MPs may 
be a more specific marker in diagnosis, measurement of progression, and risk sensitivity in chronic disease. In an 
in vitro model of vascular inflammation, pCRP was anti-inflammatory and mCRP was pro-inflammatory for 
macrophage and T cell polarization. When we further investigated pCRP under defined conditions, we found 
that pCRP in the absence of a phosphocholine ligand had no inflammatory consequences. When combined with 
phosphocholine ligands, pCRP signaled through two Fcγ receptors (FcγRI and FcγRII) via phosphorylation of 
spleen tyrosine kinase (pSYK) to activate monocytes. Phosphocholine itself, when bound to pCRP, induced a 
congruent M2 macrophage and Th2 response. Phosphocholine is also the head group on the lipid 
phosphatidylcholine, which can become oxidized. Liposomes bearing oxidized phosphatidylcholine without 
pCRP promoted a uniform M1 macrophage and Th1 pro-inflammatory response. When oxidized liposomes were 
bound to pCRP, there was a disjunction in the macrophage and T cell response: monocytes matured into M2 
macrophages, but the T cells polarized into a Th1 phenotype. The CRP-bound liposomes signaled monocytes via 
FcγRII to promote an anti-inflammatory M2 macrophage state, whereas the lack of FcγR on T cells allowed their 
liposome-induced polarization to a pro-inflammatory Th1 phenotype unopposed by the contribution of the 
pCRP/FcγR interaction. Different isoforms of CRP and its binding to complex ligands may determine its 
biological activities and their contribution to inflammatory states. 
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Introduction 
CRP is an ancient molecule that existed prior to the 
evolutionary advent of complement or the acquired immune 
system [1]. It had a role, now maintained even in higher 
organisms, of nonself recognition mediating innate immunity 
[2]. It has been suggested that the functions of CRP became 
less essential with the development of more complex 
immunity [3], and yet there are few species that have lost the 
ability to make it, and no known human cases of genetic 
absence. It is part of the innate immune rapid response to 
infectious organisms, especially in overwhelming infections 
such as sepsis. In sterile tissue damage, it is also one part of 
the overall inflammatory response, in which it may have 
multiple, even opposing, roles depending on its molecular 
form. In this Research Highlight, we discuss our new 
findings concerning the different structural forms of CRP, 
their presence in peripheral artery disease, and their 
mechanism of action [4, 5]. 
CRP found in the circulation is produced and secreted by 
the liver as a soluble pentamer (pCRP) of five identical 
monomeric subunits [6]. When pCRP is exposed to conditions 
that separate individual subunits, the resultant monomeric 
CRP (i.e. mCRP) undergoes a conformational rearrangement 
that makes it substantially less soluble and new antigens are 
exposed [7] (Figure 1). However, the exact structure of mCRP 
is unknown: it may form dimers or trimers with the altered 
conformation. In looking for naturally occurring substances 
that could affect the dissolution of pCRP into mCRP, we and 
others have found that this process can be aided by lipids [4,
8]. In the body, lipids derived from cell membranes, apoptotic 
bodies, microparticles, or LDL cholesterol particles can 
subserve that function [9-11]. To study individual CRP 
monomers in vitro, the pentamer can be relaxed by 
denaturants such as urea, detergents, and lipid monolayers or 
bilayers; the resultant monomers cannot reassemble, and stay 
in the lipid environment because of their hydrophobicity. 
Individual CRP subunits dissociated from those found in the 
pentameric configuration are structurally and functionally 
distinct and are described as “modified, monomeric” CRP or 
“mCRP.”  The released monomeric subunits reveal new 
epitopes for antibody recognition and monoclonal antibodies 
that clearly distinguish pCRP or mCRP [12] were used in the 
studies we describe herein. As described in this report, 
mCRP antigen in plasma can be detected only as a complex 
with lipid containing microparticles. mCRP, both as an 
isolated protein and as a lipid complex, is now widely 
recognized as a biologically active form of “CRP” with 
potent pro-inflammatory activities in contradistinction to 
pCRP [13].   
To identify naturally occurring substances that could elicit 
the release of mCRP from pCRP, we evaluated the role of 
microparticles derived from TNF-α stimulated cultured 
human cardiac endothelial cells or measured in plasma from 
patients with peripheral artery disease. Both pCRP and 
mCRP have been found on the surface of microparticles, 
which are ~100-1000 nm vesicles that have budded from the 
cell surface and contain part of the outer cell membrane as 
well as internal cellular components. Thus, just as artificial 
lipid membranes have been shown to promote the relaxation 
of the CRP pentamer into its component monomers, a similar 
dissociation of pCRP into mCRP has been reported to occur 
on naturally produced microparticles [11]. The particular 
relevance to these findings in all clinical and diagnostic 
studies of CRP-involved inflammatory disorders is that, 
while pCRP is freely soluble and easily quantifiable in 
plasma, the mCRP isoform is not freely soluble and is only 
found associated with particles or in atheromas. Identifying 
and quantifying mCRP in plasma thus requires specialized 
reagents and techniques that address the confounding 
contributions of lipids to measurement techniques. This 
communication summarizes these findings and discusses 
their potential biological significance to immunobiology and, 
potentially, to pathophysiology. 
Potential clinical relevance  
We initially asked if standard clinical high sensitivity CRP 
(hsCRP) assays could detect mCRP or pCRP on 
microparticles, and found that they could not, even when the 
microparticles were deliberately loaded with either form of 
CRP. They also could not detect urea-solubilized mCRP. 
hsCRP assays, therefore, may only measure the portion of 
total CRP in plasma that is in the soluble pentameric form 
(soluble pCRP). However, using imaging flow cytometry and 
antibodies that distinguish between pCRP and mCRP, we 
were able to measure both forms of CRP on microparticles, 
revealing a compartment of CRP not currently measured in 
clinical blood samples (Figure 2). We then investigated the 
presence of both CRP isoforms on microparticles in the 
plasma of control donors versus that of patients with 
peripheral artery disease (PAD). For that study, we also used 
antibodies defining microparticles originating from different 
cell types. We hypothesized that cell specificity might detect 
the site of specific pathophysiologic events. Consistent with 
PAD being a vascular disease, we found a large increase in 
microparticles from endothelial cells in patients compared to 
controls. Further, there were more endothelial microparticles 
carrying mCRP, but no increase in those bearing pCRP, in 
patients (Figure 2). By contrast, there was no increase in 
microparticles of platelet or monocyte origin. We postulated 
that the increase in microparticles carrying mCRP could have 
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resulted from an enhanced conversion of pCRP to mCRP on 
the endothelial microparticles of patients.  
This possibility was further suggested by our finding that 
the number of mCRP-bearing endothelial microparticles was 
also highly correlated with the amount of low-density 
lipoprotein cholesterol (LDL) found in the patient blood. 
Although we did not measure the oxidation state of the LDL 
in patient plasma, CRP can only bind to oxidized (as opposed 
to unoxidized) phospholipids [14] (Figure 3), and lipids are a 
Figure 1. Molecular models of CRP isoforms. The pentameric form of CRP (pCRP), which 
exposes hydrophilic residues, is induced by lipids or urea to relax into hydrophobic monomeric 
subunits (mCRP) that expose novel antigenic residues. These altered monomers may associate into 
dimers or trimers, as illustrated. 
Figure 2. Schema of results from different types of analysis for CRP isoforms. Soluble pCRP in 
blood is the only form of CRP measurable by an hsCRP assay. pCRP and mCRP on microparticles 
were found by imaging flow cytometry, which identified microparticles by lactadherin binding and 
endothelial cell of origin by anti-CD144 binding. The number of endothelial microparticles bearing 
mCRP was elevated in PAD patients. 
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critical part of the mechanism for dissociating pCRP into 
mCRP [8, 15]. Thus, higher levels of LDL, and possibly its 
oxidation, may be a component of processes that include 
greater conversion of pCRP to mCRP on microparticles.  
Oxidized LDL is a known risk factor for cardiovascular 
disease [16, 17], even in healthy individuals [18], and so further 
investigations into these relationships is warranted. It is vital 
to find the best indicator of disease progression for clinical 
use, but it is also important to reveal the biological bases so 
that rational interventions can be designed. These data 
suggest that microparticle-bound mCRP is an important 
biological marker and that one important ligand for mCRP 
could be oxidized lipoprotein bound to LDL on endothelial 
cells. The interaction of CRP with LDL and other factors in 
atherosclerosis has recently been reviewed, although without 
consideration of CRP isoforms [19]. 
Potential biological relevance 
To investigate further the biological relevance and 
consequences of the two forms of CRP, we employed an in 
vitro model of leukocyte transmigration across human 
cardiac microvascular endothelium (transendothelial 
migration, TEM). We observed the consequences of pCRP 
versus mCRP on the maturation of monocytes into polarized 
macrophages. We assessed M1 (proinflammatory) and M2 
(anti-inflammatory, profibrotic) macrophage polarization and 
T cell polarization after TEM in the presence of the two CRP 
isoforms. Previous reports of CRP’s biological activity had 
concluded that it was proinflammatory. Our investigation 
found that pCRP was anti-inflammatory (and profibrotic), 
whereas mCRP was the pro-inflammatory isoform (Figure 
4).  
T cells can drive macrophage polarization by means of 
cytokines. For example, Th1 cell production of IFN-γ 
polarizes macrophages to an M1 phenotype, whereas Th2 
cell-derived IL-13 promotes the corresponding M2 
macrophage polarization. Conversely, macrophage 
polarization in an early innate immune response can 
influence T cell polarization, and so the two types of 
immunity are generally aligned. Therefore, as expected, the 
M2 macrophage profibrotic response to pCRP was 
accompanied by a Th2 T cell response (also 
anti-inflammatory and profibrotic). Likewise, mCRP induced 
not only an M1 macrophage response, but a matching Th1 
response (pro-inflammatory) (Figure 4). Thus, elements of 
the innate immune response (monocyte/macrophage) 
responded in the same direction of polarization as members 
of the acquired immune system (T cells) under these 
conditions. Other reports have also indicated that purified 
Figure 3. Molecular model of oxidation of phosphatidylcholine. The model shows the truncation 
of one fatty acid chain by oxidation (black arrow), as well as the straightening of the phosphocholine 
head group (orange arrows) allowing CRP to bind. The CRP illustrated is the pentamer shown 
perpendicular to its planar orientation (on edge). 
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CRP (likely in the pentameric form) is not pro-inflammatory 
[20-22], whereas mCRP is [23-25]. Further research to determine 
the dominant response when both isoforms are present on the 
same microparticle is clearly necessary to understand more 
fully the consequences for disease states. 
CRP binding to ligands is essential for bioactivity 
We have recently extended our studies of the pentameric 
form of CRP into questions concerning its ligands and mode 
of signaling [5]. To make our model of endothelial 
transmigration more defined, we used a serum-free 
environment with two different CRP ligands that are relevant 
to cardiovascular disease: phosphocholine and an oxidized 
phospholipid.  
Phosphocholine is a terminal head group of the 
lipoteichoic acid component of the cell walls of some Gram 
positive bacteria, including Streptococcus pneumoniae. This 
and other organisms are known to infect the heart [26] or have 
been found in atheromatous plaques [27]. Phosphocholine is 
also the head group on the lipid phosphatidylcholine. The 
exposure of the PC group on such lipids can be regulated by 
oxidation, which straightens the PC conformation and makes 
it available for CRP binding (Figure 3). We modeled the 
interaction of CRP with oxidized phosphatidylcholine by 
making multilamellar liposomes with unoxidized 
phosphatidylcholine, to which CRP does not bind, mixed 
with a small percentage of a partially oxidized 
phosphatidylcholine, as might be found in LDL.  
We found that when we used serum-free conditions in our 
assay, CRP without ligands had no effect on macrophage 
polarization. However, when bound to phosphocholine, CRP 
promoted the M2 polarization of macrophages and Th2 
polarization of T cells, as would be expected for congruent 
innate and acquired immune responses. By contrast, when 
CRP was bound to liposomes containing oxidized 
phosphatidylcholine, a different pattern emerged. Although 
M2 differentiation of macrophages was induced, the T cells 
in the assay became polarized to a Th1 phenotype, with 
production of proinflammatory IFN-γ; i.e., there was a 
“mismatch” between the macrophage and T cell responses. 
Oxidized lipids alone have been reported to induce M1 
macrophage and Th1 T cell responses [28, 29], which could 
explain the Th1 polarization in our model. We discovered 
that the disjunction between the macrophage and T cell 
responses in our liposome studies was caused by rapid 
signaling of the CRP-liposome combination through Fcγ 
receptors on the monocytes. T cells do not express Fcγ 
receptors, and therefore retained their Th1 response. Both 
FcγRI and FcγRII signaled through spleen tyrosine kinase 
(SYK), a transcription factor responsible for cellular 
activation. The subsequent M2 macrophage response, which 
resulted in the production of autocrine IL-13, was 
insufficient to oppose the oxidized lipid-induced polarization 
Figure 4. Polarization of monocytes and T cells by CRP isoforms. In the TEM assay, performed 
in the presence of fetal bovine serum, the addition of pCRP causes the maturation of monocytes into 
M2 macrophages and T cells polarize to a Th2 phenotype. This results in an anti-inflammatory and 
profibrotic environment characterized by the production of interleukin-13 (IL-13). The addition of 
urea-solubilized mCRP results in M1 macrophage maturation and Th1 polarization, resulting in a 
pro-inflammatory environment characterized by the production of interferon-γ (IFN-γ). 
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of T cells into a proinflammatory Th1 phenotype (Figure 5). 
In this case, the macrophage polarization to the M2 
phenotype preceded and was independent of the T cell 
response and could not subsequently influence it. Thus, the 
evolved response to infectious microorganisms, represented 
by CRP binding to phosphocholine moieties expressed on the 
surface of the microorganisms, may lead to resolution of 
inflammation, represented by an M2/Th2 response, whereas 
the proinflammatory influence of oxidized lipids may be 
ameliorated by pCRP in the case of macrophages, but not T 
cells. This may lead to the coexistence of pro- and 
anti-inflammatory/profibrotic conditions in the 
atherosclerotic plaque that has been described by others [30,
31].  
The binding of pCRP to oxidized lipids relaxes the 
pentamer into mCRP subunits, which promotes the 
maturation of monocytes into M1 proinflammatory 
macrophages. M1 macrophages generate reactive oxygen 
species that can oxidize lipids. We speculate that this 
sequence of events may represent a feed-forward effect that 
promotes further generation of mCRP from pCRP on lipid 
membranes (Figure 6) and maintains the pro-inflammatory 
state. 
Evolutionary advantages of multiple CRP isoforms 
pCRP binds phosphocholine head groups on bacterial cell 
wall components and phospholipids in blood and on cells. 
Even before the evolution of the acquired immune system 
and complement, it likely served as a way to remove 
microorganisms and dead cells from the body. It was then 
integrated into more complex immune systems as they 
evolved, and now may serve a variety of functions. The 
pentameric form may contribute first as an opsonin, to 
remove nonself or damaging self components, and then as a 
regulator of the stimulated inflammatory response, 
dampening inflammation by inducing an M2/Th2 response. 
If the threat to survival remains paramount, however, the 
oxidized phospholipids created and expressed during the 
acute phases of the host defense response may contribute to 
the disruption of the pCRP conformation to produce mCRP, 
which is predominantly expressed as a complex with lipids.   
In a tightly controlled, productive inflammatory response, 
generation of mCRP could contribute important protection 
against the substance that threatened health and homeostasis. 
It may normally amplify the initial response to a threat by 
inducing inflammation transiently, and then be cleared along 
with the instigating substance. If, however, the instigator 
remains present chronically, then the continuous generation 
Figure 5. Polarization of monocytes and T cells by CRP bound to different ligands and 
liposomes alone. PC alone does not signal immunocytes to polarize, and so is not represented in 
this schema. PC plus CRP signals via FcγRI to phosphorylate spleen tyrosine kinase (SYK, pSYK) 
and promote M2 macrophage maturation as well as a Th2 response. Liposomes plus CRP also 
activate SYK, but via FcγRII. However, this signal pathway for macrophages does not affect the T 
cell response, which is toward a Th1 phenotype. Liposomes without CRP induce a uniform 
proinflammatory response in both macrophages (M1) and T cells (Th1). Reprinted with permission 
[5]. 
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of mCRP may run counter to the re-establishment of 
homeostasis and lead to a persistent inflammatory disease. 
Conclusions 
The implications of these findings for human biology are 
two-fold. First, the clinical measurement of CRP by hsCRP 
assays does not reveal the entire picture of the role that CRP 
plays in chronic illness. Whether or not the inclusion of 
further aspects of CRP biology such as microparticle 
measurements (as we have reported) will aid in diagnosis or 
treatment of disease must rely on many further studies. 
Second, the understanding of the role of CRP isoforms and 
their interactions with oxidized lipids in atherosclerosis and 
other cardiovascular diseases should be expanded.  
CRP was originally isolated as a lipid-associated protein 
[32]. When lipid was removed for better protein analyses, 
CRP biochemical characteristics such as solubility, 
electrophoretic mobility, apparent isoelectric point and size, 
were changed [33]. As the field of CRP research has evolved 
over the past 50 years, the delipidated protein became the 
predominant focus of structural, functional, and clinical 
studies that currently dominate the understanding of this 
protein as a biologically relevant substance. Our current 
work gives us a new appreciation of the different forms of 
CRP, including the lipid-associated entities, and represents a 
key turning point in elucidating the multiple biological roles 
of CRP in health and disease.  
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Figure 6. Hypothetical feed-forward loop of mCRP action on macrophages and lipids. The 
differentiation of monocytes into M1 macrophages by mCRP may result in the production of reactive 
oxygen species that oxidize lipids such as phosphatidylcholine. The oxidized phosphatidylcholine, for 
example on low density lipoprotein cholesterol particles, may generate more mCRP from pCRP on 
the particles.  
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